Search Results
653 results
Your search is now limited to «Cancer Drugs» expert search.
GlobeNewswire 01/22/2019 07:30
About Marginal Zone Lymphoma Marginal zone lymphoma (MZL) comprises a group of indolent (slow growing) B-cell non-Hodgkin lymphomas (NHLs) that begin forming in the marginal zone of lymphoid tissue.
More from GlobeNewswire:
MedCity News 01/21/2019 14:01
The news comes as the company has sought to expand its presence in oncology, in particular with last week’s acquisition of Loxo Oncology for $8 billion.
More from MedCity News:
FDLI SmartBrief 01/21/2019 09:34
The FDA has issued a complete response letter to Immunomedics related to its biologics license application for sacituzumab govitecan to be used as a treatment for patients with metastatic triple-negative breast cancer who have received two or more prior therapies.
More from FDLI SmartBrief: 01/21/2019 02:18
Fiderstat could be used as chemopreventative drug for intestinal cancers caused by APC gene mutations.
More from
USAToday (United States) 01/18/2019 17:52
A drug company on Friday announced the recall of eight more lots of irbesartan blood pressure medication after testing revealed the drugs contained trace amounts of a carcinogen.
More from USAToday (United States):
NASDAQ 01/18/2019 14:51
MacroGenics Inc.'s (MGNX) updated data from its phase II clinical trial of margetuximab plus pembrolizumab for patients with advanced HER2+ gastric carcinoma has demonstrated an encouraging profile.
More from NASDAQ:
STAT 01/18/2019 13:33
After its megamerger, Celgene signs deals with two biotechs for cancer drugs.
More from STAT:
Xconomy 01/18/2019 13:18
The decision made Lilly’s drug the first new treatment for soft tissue sarcoma in more than 40 years, and it was based on data from a 133-patient, Phase 2 study that showed an olaratumab-chemo combo helped patients live longer than chemo alone ...
More from Xconomy:
Forbes 01/18/2019 13:03
Jennifer Cosgrove was 38, and a stay-at-home mom of three, when she was diagnosed with stage IV lung cancer. Twice, DNA tests gave the wrong results, but a third test led to the right result –” and saved her life. Jennifer Cosgrove, Patient Advocate,
More from Forbes:
Benzinga 01/18/2019 12:31
What Happened Immunomedics announced Thursday after the market close the FDA issued a complete response letter for its BLA for sactuzumab govitecan, its investigational candidate for metastatic triple-negative breast cancer, or TNBC, in patients who have previously received at least two prior therapies.
More from Benzinga:
ENDPOINTS 01/18/2019 11:21
Tyme Technologies on Friday touted “substantially improved survival benefit” from its experimental drug SM-88 in a single arm study in advanced pancreatic cancer patients with progression despite treatment with at least two prior therapies, but investors did not buy into the company’s enthusiasm, causing the stock $TYME to crater about 36 ...
More from ENDPOINTS:
pharmaphorum 01/18/2019 08:50
Lartruvo (olaratumab) is already approved in the US for advanced soft tissue sarcoma – but only from data from a smaller trial under the FDA’s accelerated approval scheme for badly-needed drugs.
More from pharmaphorum:
Top Class Actions 01/18/2019 07:00
Recent class action lawsuits and investigations allege that valsartan, a blood pressure drug meant to treat hypertension, may cause liver damage or cancer due to a lack of quality control at its production site factory.
More from Top Class Actions:
PharmaTimes 01/18/2019 06:44
The National Institute for Health and Care Excellence (NICE) has recommended Pierre Fabre’s Bravtovi (encorafenib) and Mektovi (binimetinib) combination as an option for some people with melanoma.
More from PharmaTimes:

Therapeutic Areas

Clinical Trials and Phases

Business Issues

Companies - Public

Companies - Venture Funded

Financial Results

Global Markets

Global Risk Factors

Government Agencies

Job Titles

Legal and Regulatory

Cell Receptors


Diagnostics and Therapeutics


Drugs - Brand Names

Drugs - Generic



Health Care

Health and Wellness

Human Anatomy

Mechanisms of Action

Medical Devices



Strategic Scenarios



On this page, you see the results of the search you have run.  You may also view the following:

  •  Click on this drop-down menu on the right hand side of the page, to choose between the machine learning-produced Insights Reports, or the listing of concepts extracted from the results, in chart or list format. 

  •  View the number of search results returned for the search in each of your collections, and click on any of those numbers to view the entire listing of results from the chosen collection.

  •  Use the search adjustment drop-downs to change the scope, sorting, and presentation of your results.

  •  Show or hide the record’s caption (content description).

  •  Show actions that can be made with the search result record.

  •  Click on the Save button after running your search, to save it so that its results will be updated each time relevant new content is added to the designated collection. You may choose to be notified via search alerts.

Click here for more info on Search Results

Click here for more info on Machine Learning applications